切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2012, Vol. 08 ›› Issue (06) : 735 -739. doi: 10.3877/cma.j.issn.1673-5250.2012.06.016

所属专题: 文献

论著

妇科化疗患者症状体验相关因素分析及对策
冯希源1, 罗碧如1,*,*()   
  1. 1. 610041 成都,四川大学华西第二医院
  • 收稿日期:2012-06-17 修回日期:2012-11-02 出版日期:2012-12-01
  • 通信作者: 罗碧如

Influential Factors and Countermeasures of Symptom Experience of Gynecologic Patients Undergoing Chemotherapy

Xi-yuan FENG1, Bi-ru LUO1()   

  1. 1. Department of Nursing, West China Second University Hospital, Chengdu 610041, Sichuan Province, China
  • Received:2012-06-17 Revised:2012-11-02 Published:2012-12-01
  • Corresponding author: Bi-ru LUO
  • About author:
    (Corresponding author: LUO Bi-ru, Email: )
引用本文:

冯希源, 罗碧如. 妇科化疗患者症状体验相关因素分析及对策[J/OL]. 中华妇幼临床医学杂志(电子版), 2012, 08(06): 735-739.

Xi-yuan FENG, Bi-ru LUO. Influential Factors and Countermeasures of Symptom Experience of Gynecologic Patients Undergoing Chemotherapy[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2012, 08(06): 735-739.

目的

了解妇科恶性肿瘤患者在化疗期间的症状体验特点,分析其影响因素,并提出护理对策。

方法

采用方便抽样法(convenience sampling),于2011年10月至2012年1月在成都市某三甲医院接受化疗的110例妇科恶性肿瘤患者进行问卷调查,应用《患者一般资料调查表》(本研究自行设计)、《记忆症状评估量表》(MSAS)、《医院焦虑抑郁量表》(HADS)对其进行调查(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,并征得受试对象的知情同意)。

结果

妇科化疗患者的症状体验总发生率居前5位的为脱发、缺乏活力/乏力、恶心、疼痛、睡眠质量低;频繁程度居前5位依次为:睡眠质量低、缺乏活力/乏力、手脚麻木或刺痛、恶心、食欲差;严重程度居前5位依次为:脱发、睡眠质量低、缺乏活力/乏力、疼痛、恶心;对患者产生的困扰程度居前5位依次为:脱发、便秘、呕吐、睡眠质量低、皮肤改变。本组调查结果显示,患者症状的总发生率、频繁程度、严重程度及困扰程度的前5位存在不一致性,但某些症状(脱发、睡眠质量低、恶心等)的发生率、严重程度、困扰程度均较高。MSAS总分为(1.82±0.74)分,多因素研究结果显示:焦虑、化疗疗程、化疗方案是症状体验的影响因素(P<0.01)。

结论

妇科化疗患者症状体验感较为严重,妇科护理工作者应对其进行有效评估,针对患者症状体验的影响因素,采取相应的护理干预和健康教育消除或缓解症状体验感,提高患者的生存质量。

Objective

To investigate the characteristics of symptom experience of the gynecologic cancer patients undergoing chemotherapy and its influencing factors.

Methods

From October 2011 to January 2012, a total of 110 gynecologic cancer patients undergoing chemotherapy were investigated with the Memorial Symptom Assessment Scale(MSAS), Hospital Anxiety and Depression Scale(HADS). Informed consent was obtained from all participates.

Results

During chemotherapy, gynecologic cancer patients experienced many symptoms including hair loss, lack of energy, nausea, pain, poor sleep, etc.. Those symptoms had higher incidence rates, occurred more frequently and seriously, and brought much more distress to gynecologic cancer patients than other symptoms.The total MSAS score was (1.82±0.74) score. And multi-factor analysis showed that the anxiety, chemotherapy course and chemotherapy regime exerted influence on the symptom experience (P<0.01).

Conclusions

Gynecologic cancer patients undergoing chemotherapy experienced more severe symptoms, so nurses should carry out effective evaluation according to patients' symptom experience, and take corresponding nursing interventions and health education to eliminate or alleviate the patients' symptoms experience, so as to improve the patients' quality of life.

表1 妇科化疗患者症状体验发生情况(n=104)
Table 1 The state of symptom experience of the gynecologic cancer patients undergoing chemotherapy (n=104)
项目 总发生率 频繁程度 严重程度 困扰程度
n(%) 排序 n(%) 排序 n(%) 排序 n(%) 排序
脱发 86(82.70) ? 74(71.15) 55(52.88)
缺乏活力/乏力 82(78.80) 18(17.31) 41(39.42) 10 (9.62)
恶心 79(76.00) 13(12.50) 37(35.58) 12(11.54)
疼痛(腰、腹等) 77(74.00) 5 (4.81) ? 38(36.50) 8(7.69) ?
睡眠质量低 76(73.10) 23(22.10) 50(48.08) 13(12.50)
便秘 76(73.10) ? 37(35.58) 15(14.42)
出汗 74(71.15) 4 (3.80) ? 34(32.69) 10 (9.62) ?
口干 72(69.20) 9 (8.70) 29(27.88) 6 (5.77) ?
食欲差 65(62.50) 13(12.50) 34(32.69) 9 (8.65) ?
焦虑不安 60(57.70) 7 (6.70) 28(26.92) ? 7 (6.70) ?
急躁易怒 58(55.80) ? 9 (8.70) 27(25.96) ? 9 (8.65) ?
口味改变 57(54.80) ? ? 17(16.35) ? 6 (5.77) ?
精神紧张 56(53.80) ? 10(9.62) 33(31.73) 10 (9.62)
呕吐 54(51.90) ? 9 (8.65) 26(25.00) ? 14(13.46)
皮肤改变 54(51.90) ? ? 24(23.08) ? 13(12.50)
昏昏欲睡 51(49.00) ? 6 (5.80) ? 27(25.96) ? 2 (1.92) ?
感到"我看起不像自己" 51(49.00) ? ? 25(24.04) ? 11(10.58)
手脚麻木或刺痛 50(48.08) ? 17(16.30) 27(25.96) ? 11(10.58)
难以集中注意力 49(47.10) ? 6 (5.77) ? 18(17.30) ? 8 (7.69) ?
感到悲伤 47(45.20) ? 7 (6.70) ? 25(24.04) ? 9 (8.65) ?
口腔溃疡 42(40.40) ? ? 20(19.23) ? 7 (6.70) ?
眩晕 38(36.50) ? 3 (2.88) ? 18(17.31) ? 1 (0.96) ?
腹胀 35(33.70) ? 4 (3.80) ? 8 (7.69) ? 3 (2.88) ?
咳嗽 35(33.70) ? 2 (1.90) ? 7 (6.70) ? 0 (0.00) ?
皮肤瘙痒 34(32.69) ? 3 (2.90) ? 15(14.42) ? 3 (2.88) ?
对性生活失去兴趣/性生活困难 32(30.80) ? 6 (5.80) ? 14(13.46) ? 3 (2.88) ?
手臂或腿部肿胀 25(24.04) ? ? 10 (9.62) ? 2 (1.92) ?
腹泻 25(24.00) ? 3 (2.90) ? 12(11.54) ? 5 (4.81) ?
体重下降 24(23.08) ? ? 11(10.58) ? 1 (0.96) ?
呼吸困难 23(22.10) ? 2 (1.92) ? 6 (5.77) ? 1 (0.96) ?
排尿困难 18(17.30) ? 5 (4.81) ? 5 (4.81) ? 3 (2.88) ?
吞咽困难 14(13.46) ? 1 (0.96) ? 6 (5.77) ? 0 (0.00) ?
表2 年龄、住院次数等指标与MSAS评分的相关性分析(n=104)
Table 2 Correlation of the age, number of hospital days and other items and MSAS (n=104)
表3 妇科化疗患者症状体验的单因素分析(n=104)
Table 3 Single factor analysis of the gynecologic cancer patients undergoing chemotherapy (n=104)
表4 妇科化疗患者症状体验的多因素分析(n=104)
Table 4 Multi-factor analysis of the gynecologic cancer patients undergoing chemotherapy (n=104)
[1]
Rhodes VA, McDaniel RW, Homan SS, et al. An instrument to measure symptom experience. Symptom occurrence and symptom distress[J]. Cancer Nurs, 2000, 23(1):49-54.
[2]
Kurt S, Unsar S. Assessment of symptom control in patients with cancer in Northwestern Turkey[J]. Eur J Oncol Nurs, 2011, 15(2):137-144.
[3]
Zucca AC, Boyes AW, Linden W, et al. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types[J]. J Pain Symptom Manage, 2012, 43(4):720-731.
[4]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale[J]. Acta Psychiatr Scand, 1983, 67(6):361-370.
[5]
Liu W, Lu HJ, Hu Y, et al. Anxiety and depression among patients with acute myocardial infarction: The predictive factors[J]. J Nurs Sci, 2011, 26(1):70-73.
[6]
Pinar G, Okdem S, Buyukgonenc L, et al. The relationship between social support and the level of anxiety, depression, and quality of life of turkish women with gynecologic cancer[J]. Cancer Nurs, 2012, 35(3):229-235.
[7]
Cheng KK, Wong EM, Ling WM, et al. Measuring the symptom experience of Chinese cancer patients: A validation of the Chinese version of the memorial symptom assessment scale[J]. J Pain Symptom Manage, 2009, 37(1):44-57.
[8]
Zheng CH, Zhang MF, Liu K. Symptom experience in patients with gynecologic malignancies during chemotherapy[J]. J Nurs Sci, 2010, 25(4):24-27.
[9]
Deshields TL, Potter P, Olsen S, et al. Documenting the symptom experience of cancer patients[J]. J Support Oncol, 2011, 9(6):216-223.
[10]
Agarwal S, Bodurka DC. Symptom research in gynecologic oncology: A review of available measurement tools[J]. Gynecol Oncol, 2010, 119(2):384-389.
[11]
Howren MB, Suls J. The symptom perception hypothesis revised: Depression and anxiety play different roles in concurrent and retrospective physical symptom reporting[J]. J Pers Soc Psychol, 2011, 100(1):182-195.
[12]
Wu J. Symptom experience and the related factors in gastric cancer patients afterradical gastrectomy during chemotherapy[D]. Guangzhou:Zhongshan Univ, 2010.
[13]
Walker LM, Bischoff TF, Robinson JW. Supportive expressive group therapy for women with advanced ovarian cancer[J]. Int J Group Psychother, 2010, 60(3):407-427.
[14]
Hua J. Longitudinal study of symptom distress with adjuvant chemotherapy in colon cancer[D]. Shanghai:Fudan Univ, 2010.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[5] 薛庆, 施赛叶, 徐雅文, 盛夏, 张芹芹. 追踪方法学联合失效模式与效应分析在膀胱灌注化疗患者中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 553-559.
[6] 宋小飞, 巫嘉文, 孙阳. 输尿管开口周围膀胱黏膜预离断联合早期膀胱灌注化疗在上尿路尿路上皮癌根治术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 479-484.
[7] 杨慧, 郭丽娟, 冯晓丹, 李静, 黄成谋, 蔡兴锐, 覃英娇, 王远礼. 非小细胞肺癌铂类药物耐药mi RNA表达特征及预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 719-724.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[10] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 王哲学, 白峻阁, 姜得地, 李月刚, 杨明, 陈海鹏, 刘正. 局部进展期直肠癌经新辅助放化疗后肿瘤退缩分级及预后的影响因素分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 368-374.
[13] 张颖, 赵鑫, 陈佳梅, 李雁. 术前化疗对CRS+HIPEC 治疗腹膜假黏液瘤预后影响的meta 分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 826-835.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 黄晓云, 姚雅极. 院前急救医师职业寿命影响因素与对策思考[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 281-285.
阅读次数
全文


摘要